Northwest Biotherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $212.0K
Liabilities Breakdown FY2011
Total Liabilities: $52.4M
Asset Breakdown
Total Assets: $212.0K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $24.0K | 11.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $78.0K | 36.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $110.0K | 51.9% |
Liabilities Breakdown
Total Liabilities: $52.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 7.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.6M | 92.7% |